san 202791 has been researched along with calcimycin in 1 studies
| Studies (san 202791) | Trials (san 202791) | Recent Studies (post-2010) (san 202791) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 31 | 0 | 2 | 11,946 | 40 | 444 |
| Protein | Taxonomy | san 202791 (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, HR; Rotzler, S; Schramek, H | 1 |
1 other study(ies) available for san 202791 and calcimycin
| Article | Year |
|---|---|
Metabolic stabilization of endplate acetylcholine receptors regulated by Ca2+ influx associated with muscle activity.
Topics: Animals; Calcimycin; Calcium; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Electric Stimulation; Electrophysiology; Half-Life; Male; Motor Endplate; Muscle Denervation; Muscles; Organ Culture Techniques; Potassium; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Ryanodine; Tetrodotoxin | 1991 |